A REVIEW OF HSL-IN-1

), allows to explain why KIF15 will be able to facilitate resistance to Eg5 inhibitors in vivo. MT gliding driven by both of those mitotic motors was arrested only when they have been independently inhibited, lending support on the proposal that a mix drug therapy targeting these motors may be a workable tactic for beating chemotherapeutic resistan